ABCD is pleased to announce the launch of the ABCD nationwide IDegLira (Xultophy) audit and would like to invite you to take part.
The clinical trials of IDegLira seem to show in those uncontrolled on basal insulin (20-50units), IDegLira showed statistically improved HbA1c reductions in comparison to the up titration of insulin glargine U100 with fewer hypoglycamic episodes and less weight gain, and indeed with weight loss.
This year’s ABCD Clinical and Commissioning News – Live event on 6th July in London, Leeds, Bristol, and Manchester. This is of particular relevance to members practising in England.
Join us for a day of state-of-the-art updates following the ADA Scientific sessions, showcasing innovative practice and commissioning, and the chance to meet in locality groups with your commissioners.
ABCD has been asked to comment on three proposals set out in a letter from the DVLA describing the intention to amend the driving regulations for people with diabetes.
You can download the document HERE.
ABCD is pleased to announce the launch of the ABCD nationwide empagliflozin audit and would like to invite all ABCD members to take part.
In line with the 20th anniversary this year of the founding of ABCD, as of today the http://www.diabetologists-abcd.org.uk homepage is now replaced by http://abcd.care. The archive of material on diabetologists-abcd.org.uk will continue to be available as well as all the historic announcements and news items available at: http://www.diabetologists-abcd.org.uk/Lists/Announcements/AllItems.htm
20th Anniversary. This year is a landmark year for ABCD and we are celebrating our 20th anniversary. Make sure you come along to our Spring Meeting for clinical updates, sharing best practice and research and also learning more about new developments at ABCD aimed at supporting our membership.
Click HERE to find out more about the Spring Meeting (Make sure you are logged in to access member rates).
Insulin Pump Meeting
The manufacturers of Lucozade Energy Original have produced this poster (with some assistance from ABCD) designed to inform diabetes health care professionals about the change in formulation with effect from April 2017. For a while it is likely that both the old and new formulations will be on the shelves at the same time. This does not specifically address the use of this product for oral glucose tolerance testing. Our view is that it should no longer be used for this purpose as the volume required would be prohibitively large.
ABCD website announcements and news items prior to 20 March 2016 can be found if you click here. There was one from Richard Greenwood on 17 April 2004 but after that the announcements started on 1 December 2010 and there are many announcements and news items after that. There is also the old ABCD notice board at this address: https://www.diabetologists.org.uk/old_abcd_notice_board.htm
The NIHR Horizon Scanning Research and Intelligence Centre has published a horizon scanning review on new and emerging non-invasive glucose monitoring technologies in development for people with diabetes.
See: HERE On 22 April 2016 the 1 year results of ABCD’s REVISE-Diabesity research study of Endobarrier treatment for diabetes and obesity were presented at the ABCD Spring meeting in Manchester. In view of the outcome of the study, BBC Midlands Today ran a news item on 11 May 2016. The news item is now on the ABCD YouTube channel at: HERE
